Macrogenics (MGNX) Change in Inventory (2021 - 2026)
Macrogenics (MGNX) reported Change in Inventory of $1.6 million for Q1 2026, down 83.14% year-over-year from $9.4 million in Q1 2025, and up 289.17% quarter-over-quarter from -$840000.0 in Q4 2025.
Macrogenics (MGNX) Change in Inventory (2021 - 2026) Analysis & Trends
Macrogenics (MGNX) has 6 years of Change in Inventory data on file, last reported at $1.6 million in Q1 2026.
- Change in Inventory for Q1 2026 came in at $1.6 million, down 83.14% year-over-year; the trailing twelve-month figure through Mar 2026 was $73000.0 (down 99.37% YoY), and the FY2025 annual result was $7.9 million, up 261.52% from the prior year.
- Change in Inventory grew to $1.6 million in Q1 2026 per MGNX's latest filing, from -$840000.0 in the prior quarter.
- Over five years, Change in Inventory peaked at $9.4 million in Q1 2025 and troughed at -$840000.0 in Q4 2025.
- A 5-year average of $670705.9 and a median of $27000.0 in 2024 frame the typical range for Change in Inventory.
- On a YoY basis, Change in Inventory climbed as much as 34811.11% in 2025 and fell as far as 609.09% in 2025.
- A 5-year view of Change in Inventory shows it stood at $364000.0 in 2022, then tumbled by 57.42% to $155000.0 in 2023, then gained by 6.45% to $165000.0 in 2024, then sank by 609.09% to -$840000.0 in 2025, then jumped by 289.17% to $1.6 million in 2026.
- Business Quant data shows MGNX's Change in Inventory at $1.6 million in Q1 2026, -$840000.0 in Q4 2025, and -$525000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 51,468.00 |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 97.70 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Macrogenics | 260.14 Mn | 193.63 Mn | - | 1.59 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.59 Mn |
| Mar 31, 2026 | 1.59 Mn |
| Dec 31, 2025 | -840,000.00 |
| Dec 31, 2025 | -840,000.00 |
| Sep 30, 2025 | -525,000.00 |
| Sep 30, 2025 | -525,000.00 |
| Jun 30, 2025 | -151,000.00 |
| Jun 30, 2025 | -151,000.00 |
| Mar 31, 2025 | 9.43 Mn |
| Mar 31, 2025 | 9.43 Mn |
| Dec 31, 2024 | 165,000.00 |
| Dec 31, 2024 | 165,000.00 |
| Sep 30, 2024 | 2.13 Mn |
| Sep 30, 2024 | 2.13 Mn |
| Jun 30, 2024 | -133,000.00 |
| Jun 30, 2024 | -133,000.00 |
| Mar 31, 2024 | 27,000.00 |
| Mar 31, 2024 | 27,000.00 |
| Dec 31, 2023 | 155,000.00 |
| Dec 31, 2023 | 155,000.00 |